Evidence map›Paper›PMID 39727211›Full record

ArticleVirulence2025

Effect of COVID-19 infection on thyroid function status and clinical indexes among hypothyroid outpatients.

Bingxin Li, Xiaoyun Feng, Yihan Zhang, Yunhong Huang, Mingyu Gu, Haiyan Sun, Wenqian Ren, Qin Zhen, Tingting Shen, Ling Pan and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Virulence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Bingxin LiDepartment of Endocrinology and Metabolism, Shanghai General Hospital, Shanghais, China.
Xiaoyun FengDepartment of Endocrinology and Metabolism, Shanghai General Hospital, Shanghais, China.
Yihan ZhangDepartment of Endocrinology and Metabolism, Shanghai General Hospital, Shanghais, China.
Yunhong HuangDepartment of Endocrinology and Metabolism, Shanghai General Hospital, Shanghais, China.
Mingyu GuDepartment of Endocrinology and Metabolism, Shanghai General Hospital, Shanghais, China.
Haiyan SunDepartment of Endocrinology and Metabolism, Shanghai General Hospital, Shanghais, China.
Wenqian RenDepartment of Endocrinology and Metabolism, Shanghai General Hospital, Shanghais, China.
Qin ZhenDepartment of Endocrinology and Metabolism, Shanghai General Hospital, Shanghais, China.
Tingting ShenDepartment of Endocrinology and Metabolism, Shanghai General Hospital, Shanghais, China.
Ling PanDepartment of Endocrinology and Metabolism, Shanghai General Hospital, Shanghais, China.
Tingting FanDepartment of Endocrinology and Metabolism, Shanghai General Hospital, Shanghais, China.
Qin QinDepartment of Endocrinology and Metabolism, Shanghai General Hospital, Shanghais, China.
Fang LiuDepartment of Endocrinology and Metabolism, Shanghai General Hospital, Shanghais, China.
Yongde PengDepartment of Endocrinology and Metabolism, Shanghai General Hospital, Shanghais, China.
Yufan WangDepartment of Endocrinology and Metabolism, Shanghai General Hospital, Shanghais, China.
Huanbai XuDepartment of Endocrinology and Metabolism, Shanghai General Hospital, Shanghais, China.ORCID 0000-0002-4294-0274

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread rapidly, leading to an Omicron outbreak in Shanghai in mid-December after adjustments to the Coronavirus Disease 2019 (COVID-19) control strategy. To investigate the impact of COVID-19 infection among hypothyroid patients, we gathered data on the hypothyroid outpatients with COVID-19 infection during this time at the Thyroid Disease Center (TDC) of Shanghai Central Hospital. Patients were divided into two groups based on whether their hypothyroidism was caused by Hashimoto's Thyroiditis (HT): the HT and the non-HT group. We assessed the differences between pre-infection and clinical follow-up at one month (day (D) 30) and three months (D90) after COVID-19 infection. In HT group, thyroid-stimulating hormone (TSH) levels decreased significantly compared to pre-infection levels (

Indexed as

COVID-19Hashimoto DiseaseHypothyroidismOutpatientsSARS-CoV-2Thyroid GlandThyrotropinAdultAgedChinaFemaleHumansMaleMiddle AgedThyroid Function TestsTriiodothyronineThyrotropinTriiodothyronineclinical chemistry testsCOVID-19COVID-19 vaccinesHashimoto Thyroiditishypothyroidismthyroid function tests

Identifiers

PMID39727211
PMCPMC11702938

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.